Across TCGA pan-cancer cohorts, RP9P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RP9P data layer compared with 20 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RP9P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RP9P expression acts as an unfavorable survival marker.

READ are the cancer types where RP9P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.166	0.830	<.001	30	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RP9P tumor-vs-normal RNA expression · all RP9P data types